Skip to main content
Caplight Logo









PolyPhotonix

PolyPhotonix

Private
SedgefieldHealthcare & Life Scienceshttps://polyphotonix.com/

Last Round

Investment

Nov 28, 2025

Total Funding Raised

$30.29M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

PolyPhotonix is a medical technology company that designs, develops, and manufactures non-invasive, photonic-based medical devices for the treatment of diabetic eye disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

light therapydiabetic retinopathymedical deviceOLED technologysleep maskhome-based treatmentophthalmologydiabetic macular edemawearable medical devicedigital healthmedtechremote patient monitoringRPMbio-photonicshealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PolyPhotonix Comparables

Compare PolyPhotonix with similar companies based on industry and business-model similarity.

PolyPhotonix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SYSTANE
72%
Eyerising International
65%
Bayer AG
60%

PolyPhotonix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
InvestmentNov 28, 2025
DebtFeb 14, 2024
Series AJan 20, 2022
Convertible DebtJan 1, 2021
GrantMar 15, 2014

Key People

Founding team and executive leadership

Richard Kirk

CEO

Executive Team

PolyPhotonix Investors

Notable investors and investment history

PolyPhotonix investors
InvestorRounds
Growth Capital VenturesInvestment
SBRI HealthcareGrant
Revere Capital AdvisorsConvertible Debt
British Business BankConvertible Debt
Centre for Process InnovationGrant
Innovate UKGrant
FW CapitalDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 28, 2025

    $2.5M round with Growth Capital Ventures

  • Nov 8, 2025

    Monthly visitors increased 34% MoM, from 674 to 900.

PolyPhotonix Filings

Explore SEC and related filing metadata, where available.

PolyPhotonix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PolyPhotonix's valuation, stock price, and market status.

Is PolyPhotonix a public or private company?

PolyPhotonix is a private company.

What is the current stock price of PolyPhotonix?

PolyPhotonix is a private company with no public stock price. Caplight tracks PolyPhotonix's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is PolyPhotonix worth (valuation)?

Valuation information for PolyPhotonix is not publicly available.

Can I buy PolyPhotonix stock?

PolyPhotonix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PolyPhotonix's last funding round?

PolyPhotonix's most recent funding round was Investment on November 28, 2025.

Who are the main investors in PolyPhotonix?

Key investors in PolyPhotonix include Prevail Partners.

Will PolyPhotonix IPO soon?

No public IPO plans have been announced for PolyPhotonix.

How can I track PolyPhotonix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PolyPhotonix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSedgefield
Employee Range13
Year Founded2008
Last FundingNov 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?